Neuropace, Inc. NPCE Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by Neuropace, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The official record: Neuropace, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Neuropace, Inc.'s total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Neuropace, Inc.'s total liabilities & equity?
- Neuropace, Inc. (NPCE) reported total liabilities & equity of $98.9M in Q1 2026.
- How has Neuropace, Inc.'s total liabilities & equity changed year-over-year?
- Neuropace, Inc.'s total liabilities & equity decreased by 10.3% year-over-year, from $110.21M to $98.9M.
- What is the long-term trend for Neuropace, Inc.'s total liabilities & equity?
- Over 5 years (2020 to 2025), Neuropace, Inc.'s total liabilities & equity has grown at a 13.5% compound annual growth rate (CAGR), from $55.95M to $105.57M.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.